|
|
Volumn 76, Issue 5, 2013, Pages 889-895
|
|
2-methoxyjuglone induces apoptosis in HepG2 human hepatocellular carcinoma cells and exhibits in vivo antitumor activity in a H22 mouse hepatocellular carcinoma model
a
b
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 METHOXYJUGLONE;
ANTINEOPLASTIC AGENT;
CASPASE 3;
CASPASE 9;
CYTOCHROME C;
FLUOROURACIL;
JUGLANS CATHAYENSIS EXTRACT;
JUGLONE;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
PLANT EXTRACT;
PROTEIN BAX;
PROTEIN BCL 2;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
BARK;
CANCER MODEL;
CARCINOMA CELL;
CELL MEMBRANE;
CELL NUCLEUS;
CELL STRAIN HEPG2;
CELL STRUCTURE;
CELL VIABILITY;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG MECHANISM;
ENZYME ACTIVATION;
FLOW CYTOMETRY;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
JUGLANS CATHAYENSIS;
LIVER CELL CARCINOMA;
MALE;
MOUSE;
NONHUMAN;
PLANT ROOT;
S PHASE CELL CYCLE CHECKPOINT;
TUMOR REGRESSION;
WALNUT;
WESTERN BLOTTING;
ANIMALS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
APOPTOSIS;
CARCINOMA, HEPATOCELLULAR;
CELL CYCLE CHECKPOINTS;
DRUG SCREENING ASSAYS, ANTITUMOR;
FEMALE;
HEP G2 CELLS;
HUMANS;
JUGLANS;
MICE;
NAPHTHOQUINONES;
S PHASE;
|
|
EID: 84878219991
PISSN: 01633864
EISSN: 15206025
Source Type: Journal
DOI: 10.1021/np400025b Document Type: Article |
|
Times cited : (34)
|
|
References (21)
|
